#Sweden #MedTech #Stockholm #Interlinked AB #ReLink®

Interlinked Achieves a Significant Milestone in Distribution

Interlinked AB, a Swedish MedTech innovator, has made headlines by entering into its first substantial international distribution agreement. This agreement not only marks a significant milestone for the company but also secures a guaranteed minimum revenue of €3 million, indicating a clear endorsement of its pioneering health technology, ReLink®.

This multi-year distribution deal underlines the increasing demand for ReLink®, a cutting-edge, patented safety connector specifically engineered to prevent accidental catheter dislodgement. This innovative device prioritizes patient safety, enhances medical practices, and works to lower costs within the healthcare system. It finds application in various medical fields, including intravenous therapy, drainage systems, and even veterinary care.

Katarina Hedbeck, CEO and co-founder of Interlinked AB, expressed her enthusiasm about this landmark moment for the company, stating, “Securing guaranteed revenue of this magnitude at such an early stage of commercialization is clear validation of both the demand and the potential impact our solution can have.” Her statement highlights just how pivotal this agreement is for the company’s growth trajectory.

As part of this new international collaboration, Interlinked will see committed volumes, thereby establishing a solid foundation that encourages the rapid expansion across diverse markets. The agreement anticipates several subsequent launches while positioning Interlinked for its next phase of global growth.

The confidence expressed in the agreement also reinforces the importance of ReLink® in redefining standards for safety and reliability in healthcare settings. The MedTech industry continues to evolve rapidly, and companies like Interlinked are at the forefront, driving innovation and safety.

Interlinked is not just any MedTech firm; it operates on a CE-MDR-approved platform that aims to enhance patient safety, streamline clinical workflows, and reduce expenses associated with healthcare delivery. As the company moves forward, it welcomes conversations with investors, partners, and stakeholders who wish to engage in their growth journey as they seek to make further inroads into international markets.

To keep pace with the medical technology revolution, these agreements are significant and indicate a bright future ahead for Interlinked. As they fine-tune their expansion strategies and build new partnerships, this is certainly a company to watch in the coming years.

About Interlinked AB
Interlinked AB is an innovative Swedish company focused on revolutionizing medical safety through advanced technology solutions. Their flagship product, ReLink®, is designed to improve patient outcomes by reducing risks associated with catheter use, proving critical in today’s healthcare environments. As Interlinked embarks on a path of accelerated growth, their mission remains clear: to transform healthcare with the highest standards of safety and efficiency.

For further inquiries and updates about Interlinked’s growth, you can reach out to Katarina Hedbeck via email at email protected] or visit their website at [www.interlinked.care.

This moment marks a promising chapter in the landscape of medical technology, where innovative solutions meet the urgent needs of healthcare providers and patients alike.